AVI & Medion Expand Global Reach at VIV Asia 2025

VIV Asia is one of Asia’s top livestock exhibitions, held every two years. In 2025, it took place from March 12–14 at the IMPACT Arena in Bangkok, Thailand. With over 1,200 global livestock companies joining, Arthavena International (AVI) proudly represented Medion as its official export partner, showcasing Medion’s high-quality products at a dedicated booth.
Menghadirkan Produk Unggulan & Mempererat Hubungan dengan Pelanggan

AVI and Medion highlighted their key products at the event, including Medivac (vaccines), Mediherba (herbal products), and pet care items like flea treatments, dewormers, pet food, and cat litter. These products attracted strong interest from visitors, leading to many inquiries during and after the event.

AVI also hosted a dinner for the Medion team, international distributors, and customers. It was a chance to build stronger connections, talk about new products, and share challenges from the field.
Looking Ahead: Growth & Collaboration

Keikutsertaan dalam VIV Asia 2025 ini bersamaan juga dengan digelarnya pameran MEAT PRO dan HORTI AGRI NEXT. Hal ini memberikan kesempatan bagi Medion untuk menjajaki peluang kolaborasi yang lebih besar dan bervariasi serta menggali potensi pasar baru di luar negeri

Through this event, AVI and Medion aim to grow their presence in the global livestock market. Over the next 2–3 years, Medion plans to expand to more than 30 export countries. This will not only boost Medion’s global brand but also promote Indonesia on the world stage.

Through this event, AVI and Medion aim to grow their presence in the global livestock market. Over the next 2–3 years, Medion plans to expand to more than 30 export countries. This will not only boost Medion’s global brand but also promote Indonesia on the world stage.

Medion Achieved Good Manufacturing Practices for Fish Medicine Certification: A Testament to the Excellence of Medion’s Premix and Probiotic Fish Production Facilities

Medion, a leading company in the field of animal and fish health, has successfully attained the Good Manufacturing Practices for Fish Medicine Certification for its premix and probiotic production facilities. These two product categories play a pivotal role in enhancing the health, immunity, and productivity of the fisheries industry. As part of its commitment to innovation and quality, Medion ensures that its products meet the highest industry standards in accordance with the CPOIB guidelines set forth in the Director-General of Aquaculture Regulation No. 187 of 2023.

Audit CPOIB dilaksanakan tanggal 13-14 November 2024 oleh auditor Bapak Anak Agung Gede Eka Susila, S. Pi., M.Sc, dan Andriani D. E, SH dari UPT Badan Pengendalian dan Pengawasan Mutu Hasil Kelautan dan Perikanan (BPPMHKP) Bandung, serta drh. Adam Saba Anggara dari BPPMHKP Pusat. Audit diawali dengan pembukaan, pengecekan ke gudang bahan baku, fasilitas produksi, lab uji mutu, gudang produk jadi dan fasilitas pendukung berupa WTP (Water Treatment Plant), dan IPAL (Instalasi Pengolahan Air Limbah). Hal ini dilakukan untuk memastikan proses produksi dari mulai penerimaan bahan baku hingga produk dirilis sesuai dengan standar yang berlaku, dan pengelolaan limbah yang tidak mencemari lingkungan sekitar.

The audit continued with a thorough review of production records, standard operating procedures (SOPs), and the alignment between documented processes and actual practices on the ground. The session concluded with the presentation of audit findings, during which the auditors commended Medion for its adherence to the expected standards, and provided constructive recommendations for ongoing improvements.

Ultimately, Medion was awarded the prestigious CPOIB certification for the Premix and Probiotic scope, achieving the highest possible rating, P1. This certification underscores Medion’s unwavering commitment to delivering innovative and high-quality products, produced through fully standardized processes. With the continued enhancement of its quality management system, Medion is well-positioned to contribute to the sustainable growth and advancement of Indonesia’s fisheries industry. Through this certification, Medion reaffirms its dedication to maintaining the highest operational and environmental standards in every aspect of its production.

Proving Commitment to Quality and International Standards, Medion Successfully Hosts First Virtual GMP Inspection

Medion has long prioritized excellence and quality in the production of its products, a commitment that is clearly reflected in the achievement of Good Manufacturing Practice (GMP) certification, both at the national and international levels.

On October 31st, 2024, Medion marked a significant milestone by conducting its inaugural Virtual GMP Inspection from Pakistan. This inspection, organized by the Drug Regulatory Authority of Pakistan (DRAP), was a critical part of the re-certification process for Medion's GMP certification, a prerequisite for the registration of products in Pakistan.

The event commenced with an introduction to Medion's personnel and company profile by Andri Yulius, Assistant Manager for International Markets, and Apt. Agung Setiawan, S. Farm, Assistant Manager of Biological Product Quality Assurance. This was followed by a virtual plant tour, conducted via live camera feed, which provided an in-depth view of the vaccine production process—from raw material preparation to the storage of finished products in the warehouse. The session concluded with a Q&A segment with the inspectors.

The inspection results indicated that Medion's vaccine production facilities fully comply with the stringent requirements outlined in GMP standards. The DRAP team, represented by Dr. Qurban Ali, Expert Member of the Registration Board, and Mr. Muhammad Zubair Masood, Deputy Director (PE&R) of DRAP, expressed their satisfaction with the high standards of Medion’s production facilities.

Medion extends its sincere gratitude for the positive feedback and recognition received. The successful application of this technology in conducting the virtual GMP inspection opens up new opportunities for Medion, positioning the company for further business expansion. This achievement underscores Medion's capability to conduct high-quality virtual inspections, and the company remains firmly committed to delivering a comprehensive range of top-tier vaccines, ensuring its competitive edge in the global market.

Joint Visit of Pharmacy Students to Medion: Exploration of the Veterinary Pharmaceutical Industry

On October 7th, 2024, Medion welcomed a group of pharmacy students to its plant in Cimareme, Bandung. A total of 35 pharmacy students from various universities in Indonesia participated, including Bandung Institute of Technology, Sekolah Tinggi Farmasi Indonesia, Ahmad Dahlan University, Gadjah Mada University, University of Indonesia, Bandung Islamic University, Jenderal Achmad Yani University, Universitas Muhammadiyah Surakarta, Muhammadiyah University of Yogyakarta, Padjadjaran University, and Islamic University of Indonesia.

The activities began with a plant tour, followed by presentations on Pharmaceutical Products by Annisa Novita Nurisma, S.ST, and Apt. Retno Widiastuti, S.Farm (Quality System Assurance). The presentation on Biological Products was delivered by Apt. Agung Setiawan Yahya, S.Farm (Quality System Assurance Assistant Manager). Subsequently, a case study was presented through a general lecture by PT. Haikal Arif, S.Farm (Technical Manager of Ananta), focusing on the theme "Product Management: Revealing the Pharmacist's Role from Product Creation to Market Launch of Pharmaceutical Products."

To wrap up the event, students were divided into groups according to their university affiliations to engage in a Campus Talk with alumni currently working at Medion. This session included discussions on job insights, career opportunities, and personal experiences during their studies, aimed at preparing students for the workforce.

The event received a warm response from participants. One of the attendees, Ananda Dhuhwiandri Berliandin Putri, a student from Gadjah Mada University, remarked that the visit was highly beneficial for soon-to-graduate students, as it broadened their understanding of job prospects and career pathways in the pharmaceutical industry. Mazaya Auliya Fikra from ITB also noted that the information provided about the extensive pharmaceutical industry was engaging, and all presenters were highly interactive.

Through this initiative, Medion aims to enhance students' knowledge of the veterinary pharmaceutical industry and illustrate the role of pharmacy students within the company.

Medion Participates in the 67th Annual Meeting of the American Association of Avian Pathologists (AAAP) in the United States

Medion is back to participated in an international conference at the 67th Annual Meeting of the American Association of Avian Pathologists (AAAP) with the theme "Maintaining Intestinal Health with Non-Antibiotic Compounds". Which has been held on on July 9th-11th , 2024 in St. Louis, Missouri, United States. It was attended by more than 700 participants from various universities, research institutions, companies, and governments.

Medion's representative, Elly Setiawaty had the opportunity to be one of the speakers and present the topic of "Cross-Protection Study of Inactivated H5N1 2.3.2.1c Vaccine against Novel H5N1 2.3.4.4b Virus Circulating in Indonesia". In addition, she also shared Medion's experience in developing an AI (Avian Influenza) vaccine which is a solution to the AI H5N1 2.3.4.4b outbreak.

Currently, the HPAI clade 2.3.4.4b virus outbreak has become a global issue. The HPAI virus from the new clade was found in Indonesia at the end of 2022 to 2023. Medion provides a comparative study on the protection of H5N1 vaccines clade 2.3.2.1c and 2.3.4.4b against the challenge of new field isolates from clade 2.3.4.4b. The homologous vaccine from clade 2.3.4.4b showed a higher level of PD50 protection than the heterologous vaccine from clade 2.3.2.1c. The administration of 1 dose of 2.3.2.1c vaccine in SPF (Specific Pathogen Free) chickens provides sub-optimal protection against the challenge of 2.3.4.4b. The vaccine is able to suppress mortality and clinical symptoms, but shows seroconversion.

The HI titer induced by the 2.3.2.1c vaccine at 3 weeks post-vaccination was lower than the 2.3.4.4b vaccine titer (3.8 vs 8.2). The antibodies produced by the 2.3.2.1c vaccine alone are not able to suppress viral shedding. The use of the 2.3.2.1c vaccine at 1 dose may protect against death, but cannot suppress the spread of the 2.3.4.4b virus. The results of the Medion study showed a low level of cross-immunity between H5N1 2.3.2.1c and 2.3.4.4b. It can be used for seroprevalent-based surveillance to indicate the presence of H5N1 2.3.4.4b challenges in chickens vaccinated only with H5N1 2.3.2.1c.

The H5N1 2.3.4.4b case, which is not widely found in Indonesia this year, is the effect of the use of the 2.3.2.1c vaccine which is still able to reduce mortality and clinical symptoms. Therefore, it is important to use homologous vaccines that are able to provide complete protection against clade 2.3.4.4b challenges. As for after the presentation of the material, the session continued with QnA from the audience.

Medion as a poultry vaccine manufacturer in Indonesia continues to be committed to being able to provide benefits to the livestock world and support the progress of animal health in Indonesia and on a global scale. This is in line with Medion's mission to contribute to all stakeholders.

Medion is Back at Indo Livestock

On Monday, 24 November 2025, Medion welcomed pharmacy students from 13 universities, including Bandung Institute of Technology (Institut Teknologi Bandung), Padjadjaran University (Universitas Padjadjaran), Jenderal Soedirman University (Universitas Jenderal Soedirman), Universitas Jenderal Achmad Yani, Bandung Islamic University (Universitas Islam Bandung), Ahmad Dahlan University (Universitas Ahmad Dahlan), Muhammadiyah University of Yogyakarta (Universitas Muhammadiyah Yogyakarta), Muhammadiyah University of Surakarta (Universitas Muhammadiyah Surakarta), Islamic University of Indonesia (Universitas Islam Indonesia), Sekolah Tinggi Farmasi Indonesia, Diponegoro University (Universitas Diponegoro), Universitas Sebelas Maret, and Jember University (Universitas Jember). The initiative was designed to provide comprehensive, first-hand exposure to the veterinary pharmaceutical industry through a company profile presentation, a guided plant tour, and a Studium Generale outlining the strategic role of pharmacists in the development of animal-health products.

Participants noted that the program was highly informative and relevant, particularly because veterinary pharmacy is rarely covered in academic curricula. Each segment of the agenda received strong appreciation for offering distinct perspectives on potential career paths, workplace dynamics, and the industrial working environment.

The visit broadened students’ understanding of professional opportunities within the veterinary sector and further strengthened collaborative ties between academic institutions and industry. Medion hopes this initiative will continue to serve as a strategic platform for cultivating future-ready talent capable of contributing to evolving needs in the animal health industry.

Medion Received Exporter Appreciation from the Embassy of the Republic of Indonesia Manila

Medion continues to be committed to producing quality and innovative products to meet the needs of all farmers. Through its extensive distribution network, Medion actively continues to expand its distribution to various countries, from Asia to Africa.

On July 9th, 2024, the Indonesian Embassy Manila held a banquet of "Familiarization Trip for Specialty Coffee and Cacao Filipino Buyers" event, at De Paviljoen Hotel. The activity was carried out to strengthen the export potential to the Philippines. Medion as one of the exporters was invited to attend the event. In this activity, the Ambassador of Manila expressed his appreciation to Medion as a company that actively contributes as an exporter of complete and quality animal health products.

Beside of exporting, Medion also actively provides education on an international scale, both technical and non-technical. Medion also contributed research results in the activity international conferences and cooperation with international institutions.

Medion hopes that with this appreciation, Medion will be able to develop the market and can strengthening bilateral relations between the two countries. For information about cooperation with Medion on an international scale, accessible through: https://www.medionfarma.co.id/en/partnering-collaboration/

Medion Resmikan Gedung Bacterial Production

Dalam rangka menambah kapasitas produksi, pengembangan produk baru, dan pemenuhan fasilitas produksi sesuai regulasi, maka pada tanggal 7 Mei 2024, Medion meresmikan bangunan baru untuk fasilitas produksi Bacterial Production yang berlokasi di Cimareme, Padalarang, Bandung. Gedung yang dibangun sesuai syarat GMP ini juga menambah mesin produksi yaitu Fermenter, agar dapat meningkatkan kapasitas serta menunjang lini produksi baru, yaitu enzim dan probiotik.

Peresmian ditandai dengan pemotongan pita oleh Jonas Jahja dan Amalia Jonas selaku founder Medion serta Melina Jonas selaku Biological Product Director Medion. Dihadiri oleh lebih dari 50 orang meliputi Board of Directors, Top Management, serta tim project Medion. Kemudian, acara dilanjutkan dengan sambutan dari Project Leader dan Project Coordinator, lalu peserta diajak plant tour fasilitas gedung dan diakhiri dengan pemotongan tumpeng dan makan bersama.

Medion juga menambahkan dua fitur baru pada gedung ini. Pertama, dilengkapi dengan building management system untuk menarik data lebih up to date terkait parameter produksi utama dan utility (water, steam, compressed air, dan lainnya). Kedua, adanya fermenter dengan fitur lebih up to date yang mengakomodir kebutuhan produk bakterial, enzym dan probiotik

Medion berharap melalui Gedung Bacterial Production ini, dapat menghasilkan produk-produk inovatif sehingga dapat menjawab kebutuhan kesehatan ternak di Indonesia. Didukung dengan komitmen untuk mengembangkan ide dan inovasi agar dapat bermanfaat bagi perusahaan dan masyarakat luas.

Libas Habis Kolibasilosis

Beni Ludianto, manager plasma peternakan ayam pedaging Agus Black Hoe Farm membagikan pengalamannya dalam mengatasi serangan bakteri E. coli saat dihubungi Infovet.

Lebih dari tiga tahun, Beni berkecimpung dalam bidang peternakan ayam pedaging. “Awalnya hanya satu kandang closed house berlantai tiga dengan kapasitas 60.000 ekor. Kemudian, menambah satu kandang lagi dengan kapasitas yang sama,” papar peternak yang tinggal di kota Ngawi itu.

Kini, Beni sedang dalam proses untuk menambah satu kandang closed house lagi berkapasitas 75.000 ekor. “Jadi dua kandang sudah ada di Kecamatan Kasreman dan satu tambahan di Kecamatan Pitu, Desa Kali Kangkung, semuanya ada di Kabupaten Ngawi,” imbuh Beni yang sebelumya justru berpengalaman bekerja di bidang pertanian.

Lulusan STM tahun 2008 itu, memulai usahanya dari nol dan tak ada pengalaman sebelumnya sehingga ia bingung ketika ayam peliharaannya yang berumur dua minggu banyak mengalami kematian. “Ayam lesu, tak mau makan, pertumbuhan berhenti dan kematian lebih dari 8.000 ekor dari populasi 60.000 ekor atau hampir 14%,” ceritanya.

Dalam menghadapi masalah pada ternaknya ia selalu berkonsultasi dengan pihak kemitraan dan dipertemukan dengan personil dari Medion. Setelah ada kunjungan ke farm dari personil Medion, akhirnya Beni memahami faktor penyebab bakteri E. coli sampai berkembang biak di farm-nya. Outbreak kolibasilosis terjadi akibat rendahnya sanitasi dan kebersihan kandang dikarenakan bakteri E. coli sangat mudah mencemari lingkungan kandang. Penularannya dapat terjadi secara vertikal melalui saluran reproduksi induk ayam. Telur yang menetas kemudian akan menghasilkan DOC yang tercemar bakteri E. coli di dalam ususnya. Sedangkan penularan horizontal, salah satunya dapat melalui kontak dengan bahan atau peralatan kandang yang tercemar. Penularan biasanya terjadi secara oral melalui ransum atau air minum yang terkontaminasi feses yang mengandung E. coli atau melalui debu yang tercemar E. coli.

Ia juga menjadi paham cara untuk mengatasi penyakit kolibasilosis di peternakannya. Seperti yang ia lakukan yaitu memberikan treatment pada air minum dengan menggunakan klorin dan melakukan desinfeksi kandang dua hari sekali secara rutin. Selain itu penting juga melakukan manajemen litter supaya tidak basah atau lembab dan mengatur sirkulasi di dalam kadang dengan baik.

Penanganan kolibasilosis dapat dilakukan dengan pemberian antibiotik seperti REMISIN. Penggunaan REMISIN dengan dosis 0,2 gr/kg berat badan yang diberikan dua kali sehari, sore dan malam hari terbukti mampu menekan kematian akibat kasus kolibasilosis hingga 3%. Dalam melakukan penanganan penyakit bakterial seperti kolibasilosis, Beni melakukan rolling dari penggunaan REMISIN ke obat antibiotika lain dari golongan yang berbeda, misalnya antibiotik golongan Fluoroquinolon setelah tiga kali periode pengobatan. Hal tersebut dilakukan untuk mencegah terjadinya resistensi antibiotika.

“Untuk mengatasi kolibasilosis yang bisa menyerang ayam di semua umur, saya menggunakan REMISIN pada air minum ayam yang sakit sejak DOC chick-in di kandang. Saya berharap kasus kematian terus turun dengan kualitas obat yang terjaga dan ditingkatkan,” tukasnya.

Selain itu, ia juga akan terus fokus menambah populasi ayamnya karena dengan begitu akan menambah lapangan pekerjaan di daerah kelahirannya. Kegigihan dan pengalaman serta kinerjanya patut diapresiasi, seperti ketika Beni tuntas melibas habis kasus kolibasilosis melalui manajemen pemeliharaan yang ketat. (ADV)